Support for developing new treatments in heart, lung, and blood health.
Official title: NHLBI CATALYZE COORDINATING CENTER - PRODUCT DEVELOPMENT SUPPORT SERVICES YEAR 2
Funded at Research Triangle Institute · NIH-11215073 · Data updated 2026-11-12
This study is looking at ways to help researchers work better together to develop new treatments for heart, lung, and blood health, which could lead to better care for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Triangle Institute NIH-funded |
| Lab location | 1 site (Research Triangle Park, United States) |
| Project start | September 13, 2024 |
| Project end | September 12, 2025 |
| Funding year | 2024 |
| Award (this year) | $1,934,229 |
| NIH project number | 92023A04092024F00001-0-0-1 |
| Project ID | NIH-11215073 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit are individuals with conditions related to heart, lung, or blood health.
✕Less likely to help
Patients with unrelated health conditions or those not affected by heart, lung, or blood issues may not receive any benefit from this research.
What this research studies
This research focuses on enhancing the Catalyze Coordinating Center's ability to manage and support preclinical development initiatives related to heart, lung, and blood health. By transitioning to a contract mechanism, the center aims to create a more agile and collaborative environment for researchers and developers. Patients may benefit from the improved coordination and management of projects that could lead to new treatments and therapies in these critical health areas.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative treatments for heart, lung, and blood conditions.
How similar studies have gone: Other research initiatives focused on preclinical development in similar health areas have shown promise, indicating a potential for success with this approach.
Where this research is happening
-
Research Triangle Institute
Research Triangle Park, United States Active
Researchers
- Principal investigator: Severynse-Stevens, Diana M — Research Triangle Institute
- Study coordinator: Severynse-Stevens, Diana M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.